SCHEMBL25436685

SCHEMBL25436685

CC1(C)CCCC2(C)C(CO)C(=O)CCC12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PNLIP P16233 3/20 0.46
▸ RPS6KA5 O75582 2/20 0.45
▸ MAPKAPK2 P49137 2/20 0.45
▸ PTPN1 P18031 3/20 0.44
▸ PTPN2 P17706 2/20 0.44
▸ PLA2G2A P14555 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ TRPV1 Q8NER1 1/20 0.39
▸ CYP19A1 P11511 2/20 0.38
▸ UGT2B7 P16662 1/20 0.38
▸ ATP1A1 P05023 1/20 0.37
▸ ATP1B1 P05026 1/20 0.37
▸ ATP1A3 P13637 1/20 0.37
▸ ATP1B2 P14415 1/20 0.37
▸ ATP1A2 P50993 1/20 0.37
▸ ATP1B3 P54709 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31592688 1.00 PNLIP (0.46) PNLIPRPS6KA5MAPKAPK2PTPN1PTPN2
SCHEMBL25439738 1.00 PNLIP (0.46) PNLIPRPS6KA5MAPKAPK2PTPN1PTPN2
SCHEMBL30585227 1.00 PNLIP (0.46) PNLIPRPS6KA5MAPKAPK2PTPN1PTPN2
SCHEMBL25434656 1.00 PNLIP (0.46) PNLIPRPS6KA5MAPKAPK2PTPN1PTPN2
SCHEMBL30585221 0.84 PNLIP (0.42) PNLIPRPS6KA5MAPKAPK2PTPN1PTPN2
SCHEMBL14722991 0.81 PTPN2 (0.44) PNLIPRPS6KA5MAPKAPK2PTPN1PTPN2
SCHEMBL12658772 0.81 PTPN2 (0.44) PNLIPRPS6KA5MAPKAPK2PTPN1PTPN2
SCHEMBL15945065 0.81 PTPN2 (0.44) PNLIPRPS6KA5MAPKAPK2PTPN1PTPN2
SCHEMBL25394905 0.81 PNLIP (0.58) PNLIPRPS6KA5MAPKAPK2PTPN1PTPN2
SCHEMBL16259419 0.81 PNLIP (0.58) PNLIPRPS6KA5MAPKAPK2PTPN1PTPN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250171391-A1 PROCESS FOR PREPARING OCTAHYDRO-2(1H)-NAPHTHALENONE DERIVATIVES FIRMENICH SA (CH) 2025-05-29 — — US disclosed
EP-4479369-A1 PROCESS FOR PREPARING OCTAHYDRO-2(1H)-NAPHTHALENONE DERIVATIVES Firmenich SA (CH) 2024-12-25 — — EP disclosed
WO-2023156429-A1 PROCESS FOR PREPARING OCTAHYDRO-2(1H)-NAPHTHALENONE DERIVATIVES FIRMENICH SA (CH) 2023-08-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171391-A1 PROCESS FOR PREPARING OCTAHYDRO-2(1H)-NAPHTHALENONE DERIVATIVES POR, NDUFV1, NDUFV2 PNLIP 1966/4885RPS6KA5 684/4885MAPKAPK2 1677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback